{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T13:05:25Z","timestamp":1777554325786,"version":"3.51.4"},"reference-count":4,"publisher":"SAGE Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatitis"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1097\/der.0000000000000488","type":"journal-article","created":{"date-parts":[[2019,5,27]],"date-time":"2019-05-27T05:04:53Z","timestamp":1558933493000},"page":"272-274","source":"Crossref","is-referenced-by-count":8,"title":["Allergic Contact Dermatitis to Crisaborole"],"prefix":"10.1177","volume":"30","author":[{"given":"Rebecca S.","family":"Kimyon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie P.","family":"Schlarbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujie Linda","family":"Liou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara A.","family":"Hylwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin M.","family":"Warshaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2019,5,29]]},"reference":[{"issue":"4","key":"bib1-20210211","first-page":"390","article-title":"Crisaborole topical ointment, 2%: a nonsteroidal, topical, anti-inflammatory phosphodiesterase 4 inhibitor in clinical development for the treatment of atopic dermatitis","volume":"15","year":"2016","journal-title":"J Drugs Dermatol"},{"issue":"1","key":"bib2-20210211","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12016-018-8705-0","article-title":"Contact dermatitis to medications and skin products","volume":"56","year":"2019","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"bib3-20210211","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.annder.2007.12.003","article-title":"Contact allergy with tacrolimus then pimecrolimus","volume":"135","year":"2008","journal-title":"Ann Dermatol Venereol"},{"issue":"2","key":"bib4-20210211","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/cod.13142","article-title":"Allergic contact dermatitis caused by mupirocin and pimecrolimus","volume":"80","year":"2019","journal-title":"Contact Dermatitis"}],"container-title":["Dermatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DER.0000000000000488","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:04:54Z","timestamp":1777399494000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1097\/DER.0000000000000488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,29]]},"references-count":4,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/der.0000000000000488","relation":{},"ISSN":["2162-5220","1710-3568"],"issn-type":[{"value":"2162-5220","type":"electronic"},{"value":"1710-3568","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5,29]]}}}